Free Trial

Rhythm Pharmaceuticals (RYTM) SEC Filings & 10K Form

$49.57
+0.31 (+0.63%)
(As of 04:16 PM ET)

Recent Rhythm Pharmaceuticals SEC Filings

DateFilerForm TypeView
07/18/2024
4:59 PM
Rhythm Pharmaceuticals (Issuer)
Shulman Joseph (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/16/2024
3:30 PM
Rhythm Pharmaceuticals (Issuer)
Shulman Joseph (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/16/2024
3:37 PM
Rhythm Pharmaceuticals (Subject)
Shulman Joseph (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/12/2024
3:34 PM
Rhythm Pharmaceuticals (Subject)
Shulman Joseph (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/10/2024
4:00 PM
Garfield Alastair (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
07/10/2024
4:01 PM
Garfield Alastair (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/10/2024
3:05 PM
Rhythm Pharmaceuticals (Filer)
Form 424B7
07/10/2024
3:07 PM
Rhythm Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/25/2024
3:39 PM
MCGIRR DAVID W J (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2024
3:41 PM
Arbuckle Stuart A (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2024
3:30 PM
GOOD JENNIFER L (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2024
3:35 PM
JEAN CHRISTOPHE (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2024
3:37 PM
Bedrosian Camille L (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2024
3:38 PM
Mathers Edward T (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2024
3:38 PM
Rhythm Pharmaceuticals (Issuer)
TETRAULT LYNN A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
8:44 PM
MCGIRR DAVID W J (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
8:47 PM
Rhythm Pharmaceuticals (Issuer)
TETRAULT LYNN A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
8:38 PM
Arbuckle Stuart A (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
8:39 PM
GOOD JENNIFER L (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
8:41 PM
Bedrosian Camille L (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
8:42 PM
JEAN CHRISTOPHE (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
8:43 PM
Mathers Edward T (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2024
4:28 PM
Rhythm Pharmaceuticals (Filer)
Form DEFA14A
06/17/2024
4:19 PM
Rhythm Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/07/2024
3:43 PM
Rhythm Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/07/2024
6:10 AM
Rhythm Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/30/2024
6:31 PM
NEW ENTERPRISE ASSOCIATES 13 LP (Filed by)
Rhythm Pharmaceuticals (Subject)
Form SC 13D/A
04/26/2024
3:13 PM
Rhythm Pharmaceuticals (Filer)
Form ARS
04/17/2024
3:15 PM
PERCEPTIVE ADVISORS LLC (Filed by)
Rhythm Pharmaceuticals (Subject)
Form SC 13D/A
04/16/2024
7:11 PM
Mazabraud Yann (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/16/2024
6:00 AM
Rhythm Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/03/2024
7:00 PM
German Christopher Paul (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2024
5:18 PM
PERCEPTIVE ADVISORS LLC (Filed by)
Rhythm Pharmaceuticals (Subject)
Form SC 13D/A
04/01/2024
4:25 PM
Rhythm Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/22/2024
3:55 PM
Rhythm Pharmaceuticals (Issuer)
Shulman Joseph (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/21/2024
3:21 PM
Rhythm Pharmaceuticals (Subject)
Shulman Joseph (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/20/2024
4:51 PM
PERCEPTIVE ADVISORS LLC (Filed by)
Rhythm Pharmaceuticals (Subject)
Form SC 13D
03/20/2024
3:41 PM
Lee Jennifer Kayden (Reporting)
Rhythm Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/19/2024
7:50 PM
Cramer Pamela J. (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2024
7:52 PM
Lee Jennifer Kayden (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2024
7:53 PM
Mazabraud Yann (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
New Government Policy to Wipe Out Seniors Wealth (Ad)

Don't wait until it's too late. The digital dollar is nearing the end of its trial period, and the window of opportunity to protect your interests is closing fast.

Click Here To Get Your FREE Guide Now!
03/19/2024
7:54 PM
Meeker David P (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2024
7:56 PM
Rhythm Pharmaceuticals (Issuer)
Shulman Joseph (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2024
7:57 PM
Rhythm Pharmaceuticals (Issuer)
Smith Hunter C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/29/2024
3:58 PM
Rhythm Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/29/2024
3:44 PM
Rhythm Pharmaceuticals (Filer)
Form 424B5
02/29/2024
3:46 PM
Rhythm Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/29/2024
3:05 PM
Rhythm Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/22/2024
6:01 AM
Rhythm Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/21/2024
6:00 PM
Lee Jennifer Kayden (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2024
6:00 PM
Rhythm Pharmaceuticals (Issuer)
Shulman Joseph (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2024
6:01 PM
Rhythm Pharmaceuticals (Issuer)
Smith Hunter C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2024
6:01 PM
Cramer Pamela J. (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2024
6:02 PM
German Christopher Paul (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2024
6:02 PM
Mazabraud Yann (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2024
6:03 PM
Meeker David P (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/15/2024
5:14 PM
Rhythm Pharmaceuticals (Issuer)
Shulman Joseph (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2024
7:45 PM
Cramer Pamela J. (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2024
7:46 PM
Rhythm Pharmaceuticals (Issuer)
Shulman Joseph (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2024
7:47 PM
Lee Jennifer Kayden (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2024
7:49 PM
Mazabraud Yann (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2024
7:50 PM
Rhythm Pharmaceuticals (Issuer)
Smith Hunter C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2024
4:13 PM
Rhythm Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G
02/09/2024
3:19 PM
Rhythm Pharmaceuticals (Subject)
Shulman Joseph (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/05/2024
5:53 PM
Cramer Pamela J. (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2024
5:53 PM
Meeker David P (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2024
5:54 PM
Rhythm Pharmaceuticals (Issuer)
Shulman Joseph (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2024
5:54 PM
Rhythm Pharmaceuticals (Issuer)
Smith Hunter C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2024
5:55 PM
Lee Jennifer Kayden (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2024
4:34 PM
GOLDMAN SACHS GROUP INC (Filed by)
GOLDMAN SACHS GROUP INC (Filed by)
Rhythm Pharmaceuticals (Subject)
Form SC 13G/A
01/24/2024
8:46 AM
BlackRock Inc. (Filed by)
Rhythm Pharmaceuticals (Subject)
Form SC 13G/A
01/23/2024
8:04 AM
Rhythm Pharmaceuticals (Subject)
STATE STREET CORP (Filed by)
Form SC 13G/A
01/04/2024
6:15 AM
Rhythm Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/04/2024
6:00 AM
Rhythm Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/03/2024
3:15 PM
Rhythm Pharmaceuticals (Issuer)
Smith Hunter C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/29/2023
3:30 PM
Rhythm Pharmaceuticals (Issuer)
Shulman Joseph (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/27/2023
3:22 PM
Rhythm Pharmaceuticals (Subject)
Shulman Joseph (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/18/2023
3:16 PM
Rhythm Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/06/2023
3:30 PM
Rhythm Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/06/2023
3:34 PM
Rhythm Pharmaceuticals (Subject)
Smith Hunter C (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/24/2023
12:06 PM
Rhythm Pharmaceuticals (Subject)
Smith Hunter C (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/14/2023
3:14 PM
Lee Jennifer Kayden (Reporting)
Rhythm Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/14/2023
3:14 PM
Rhythm Pharmaceuticals (Subject)
Shulman Joseph (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/13/2023
4:44 PM
Lee Jennifer Kayden (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/08/2023
3:30 PM
Rhythm Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/08/2023
3:14 PM
Lee Jennifer Kayden (Reporting)
Rhythm Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/07/2023
5:17 PM
Lee Jennifer Kayden (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/07/2023
6:05 AM
Rhythm Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/03/2023
3:24 PM
Lee Jennifer Kayden (Reporting)
Rhythm Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/07/2023
4:48 PM
Lee Jennifer Kayden (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/07/2023
9:14 AM
FEDERATED HERMES, INC. (Filed by)
FEDERATED HERMES, INC. (Filed by)
Rhythm Pharmaceuticals (Subject)
Form SC 13G/A
New Government Policy to Wipe Out Seniors Wealth (Ad)

Don't wait until it's too late. The digital dollar is nearing the end of its trial period, and the window of opportunity to protect your interests is closing fast.

Click Here To Get Your FREE Guide Now!
09/05/2023
3:17 PM
Lee Jennifer Kayden (Reporting)
Rhythm Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/21/2023
3:30 PM
Rhythm Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/16/2023
4:50 PM
German Christopher Paul (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
08/08/2023
6:32 AM
Rhythm Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/01/2023
3:27 PM
Rhythm Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/01/2023
6:05 AM
Rhythm Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/28/2023
8:01 PM
Cramer Pamela J. (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:RYTM) was last updated on 7/19/2024 by MarketBeat.com Staff

From Our Partners